Tagged with “Lynch syndrome”

Annual Colonoscopy for Lynch Syndrome

Annual colonoscopies for people with Lynch syndrome (HNPCC or hereditary nonpolyposis colon cancer) successfully find cancers at an early stage.

A recent study by the German HNPCC Consortium confirmed the effectiveness of annual colonoscopies to find colorectal cancers at a curable stage. Regular colonoscopies found early cancers more often than did patient symptoms.

Current recommendations are for surveillance colonoscopies to begin by age 25, be repeated every 1 to 2 years until age 40, and then annually.

Posted by Kate Murphy on March 12th, 2010
Posted in: Research & Treatment News | No Comments »
Tags: colonoscopy, HNPCC, Lynch syndrome

Choosing the Best Colon Surgery for Lynch Syndrome

Removing the entire colon (subtotal colectomy) is sometimes recommended for patients with Lynch syndrome when colon cancer is diagnosed. In addition, some people who have an inherited Lynch mutation have their colons removed to prevent colon cancer.

While subtotal colectomy didn’t reduce deaths from Lynch-related colon cancer, it did cut down on additional colorectal cancer diagnoses and the need for other abdominal surgery. Continue reading…

Posted by Kate Murphy on February 5th, 2010
Posted in: Research & Treatment News | No Comments »
Tags: Lynch syndrome, subtotal colectomy, surgery

Risk for Lynch Syndrome Related Cancers in MSH6 Mutations

People with a mutation in the MSH6 gene, part of the Lynch syndrome, have a greatly increased risk of colorectal, endometrial, and other related cancers. The cancers can occur in old age, with an increasing risk from age 70 to 80.

About 4 in every 1000 colorectal cancers are due to an inherited mutation in the MSH6 gene. It accounts for about 10 to 20 percent of Lynch syndrome mutations.

By the time they are 80 years old, men have eight times the risk of getting colorectal cancer and women have 26 times the risk of endometrial cancer — cancer that begins in the lining of the uterus.

Posted by Kate Murphy on December 23rd, 2009
Posted in: Research & Treatment News | No Comments »
Tags: inherited cancer, Lynch syndrome, MSH6

Colorectal Cancer News in Brief: November 1

Sgt. Joshua T. Rose and Iron (Photo by Tina Susman)

Briefly: Pancreatic cancer occurs in about on in five Lynch syndrome families, increasing risk for the cancer substantially.

Colorectal cancer patients whose tumors don’t have EGFR on immunohistochemical testing can still benefit from Erbitux treatment.

Patients learn more and like medical consultations better when doctors sit side-by-side with them to view tests.

Gastroenterologists deployed in Iraq are using their skills to help military working dogs. Continue reading…

Posted by Kate Murphy on November 2nd, 2009
Posted in: Research & Treatment News | No Comments »
Tags: EGFR, Erbitux, Lynch syndrome, military dogs

Aspirin Prevents Lynch Syndrome Cancers

ECCO/ESMO UPDATE — BERLIN 2009

Although initial reports found no reduction in polyps or cancer in people with Lynch syndrome who took aspirin and/or resistant starch supplements, longer follow-up tells a difference story.

About five years after trial participants began taking aspirin or a placebo, differences began to emerge. Even though patients in the trial only took aspirin for four years, later followup found significantly fewer colon colon cancers among those who had used aspirin, as well as fewer Lynch-related cancers overall. There were almost three times as many colon cancers in Lynch carriers who took a placebo compared to those who used aspirin. Continue reading…

Posted by Kate Murphy on September 24th, 2009
Posted in: Research & Treatment News | No Comments »
Tags: aspirin, colorectal cancer prevention, Lynch syndrome